Sio Gene Therapies Inc. — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2021)

-$71.9M

Total Assets (FY2021)

$75.1M

Total Equity (FY2021)

$60.3M

Cash Flows from Operating Activities (FY2021)

-$60.3M

Source: Sio Gene Therapies Inc. 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.